CARDONE, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 364
AS - Asia 209
NA - Nord America 155
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 13
Totale 755
Nazione #
RU - Federazione Russa 294
US - Stati Uniti d'America 152
SG - Singapore 84
CN - Cina 49
HK - Hong Kong 31
IT - Italia 31
IE - Irlanda 20
VN - Vietnam 15
DE - Germania 11
BR - Brasile 10
IN - India 10
KR - Corea 8
JP - Giappone 4
CA - Canada 3
EC - Ecuador 3
NL - Olanda 3
PL - Polonia 2
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
ID - Indonesia 1
JO - Giordania 1
KG - Kirghizistan 1
PH - Filippine 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 742
Città #
Moscow 105
Singapore 43
San Jose 34
Hong Kong 29
Santa Clara 24
Dublin 18
Ashburn 12
Beijing 9
Hefei 9
Chandler 8
Naples 8
Seoul 8
Council Bluffs 7
Hanoi 7
New York 7
Dallas 6
Bengaluru 5
Los Angeles 5
Aversa 4
Munich 4
Amsterdam 3
Ho Chi Minh City 3
Sant'Antimo 3
Atlanta 2
Berlin 2
Bremen 2
Brooklyn 2
Cambridge 2
Florence 2
Giugliano in Campania 2
Hyderabad 2
Montreal 2
Princeton 2
Rome 2
Roxbury 2
Shanghai 2
São Paulo 2
Warsaw 2
Amman 1
Baku 1
Bishkek 1
Bologna 1
Brno 1
Cali 1
Cascavel 1
Cercola 1
Chengdu 1
Chennai 1
Da Nang 1
Des Moines 1
El Paso 1
Falkenstein 1
Guangzhou 1
Guayaquil 1
Haikou 1
Houston 1
Iporá 1
João Pessoa 1
Kayseri 1
Limburg an der Lahn 1
Manado 1
Manchester 1
Milan 1
Mumbai 1
New Delhi 1
Newark 1
Oeiras 1
Orem 1
Petersburg 1
Ponta Porã 1
Pozzuoli 1
Poções 1
Qingdao 1
Quito 1
Riyadh 1
San Diego 1
Secaucus 1
Seropédica 1
St Petersburg 1
São Bernardo do Campo 1
Taiyuan 1
The Dalles 1
Thái Nguyên 1
Tokyo 1
Toronto 1
Vienna 1
Yuen Long 1
Totale 440
Nome #
Cetuximab rechallenge plus avelumab in pretreated patients with RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial 162
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 Trial 147
Pimasertib hydrochloride 146
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 136
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial 132
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer 32
Totale 755
Categoria #
all - tutte 2.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.284


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 4 3 0 0 2 1 4
2022/202332 3 0 1 1 6 2 0 2 12 0 3 2
2023/202430 3 0 1 0 7 6 3 2 1 0 2 5
2024/2025114 2 3 0 14 18 16 18 14 10 5 3 11
2025/2026551 18 26 25 10 42 277 30 33 30 16 31 13
2026/202714 4 10 0 0 0 0 0 0 0 0 0 0
Totale 755